{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T20:04:36Z","timestamp":1774123476840,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":1482,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.rmed.2009.01.021","type":"journal-article","created":{"date-parts":[[2009,2,27]],"date-time":"2009-02-27T04:36:04Z","timestamp":1235709364000},"page":"1231-1238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"title":["Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease"],"prefix":"10.1016","volume":"103","author":[{"given":"Yuji","family":"Higashimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morihiro","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanji","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Tohda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2009.01.021_bib1","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1136\/thorax.55.9.785","article-title":"Which spirometric indices best predict subsequent death from chronic obstructive pulmonary disease?","volume":"55","author":"Thomason","year":"2000","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2009.01.021_bib2","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1183\/09031936.00082507","article-title":"Definition, epidemiology and natural history of COPD","volume":"30","author":"Viegi","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2009.01.021_bib3","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1513\/pats.200802-018ET","article-title":"Natural history of emphysema","volume":"5","author":"Minai","year":"2008","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.rmed.2009.01.021_bib4","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.rmed.2006.09.008","article-title":"Transforming growth factor-beta1 polymorphisms, airway responsiveness and lung function decline in smokers","volume":"101","author":"Ogawa","year":"2007","journal-title":"Respir Med"},{"key":"10.1016\/j.rmed.2009.01.021_bib5","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1164\/ajrccm.163.2.2006158","article-title":"Susceptibility genes for rapid decline of lung function in the lung health study","volume":"163","author":"Sandford","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2009.01.021_bib6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1183\/09031936.03.00405703","article-title":"Systemic effects of chronic obstructive pulmonary disease","volume":"21","author":"Agusti","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2009.01.021_bib7","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1183\/09031936.06.00032706","article-title":"The systemic face of airway diseases: the role of C-reactive protein","volume":"27","author":"Wouters","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2009.01.021_bib8","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1136\/thx.2003.019588","article-title":"Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis","volume":"59","author":"Gan","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2009.01.021_bib9","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1183\/09031936.05.00092804","article-title":"Increased serum concentrations of tissue inhibitor of metalloproteinase-1 in COPD patients","volume":"25","author":"Higashimoto","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2009.01.021_bib10","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1440-1843.2007.01170.x","article-title":"Systemic inflammation in chronic obstructive pulmonary disease and asthma: similarities and differences","volume":"13","author":"Higashimoto","year":"2008","journal-title":"Respirology"},{"key":"10.1016\/j.rmed.2009.01.021_bib11","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1183\/09031936.06.00109605","article-title":"C-reactive protein levels and clinically important predictive outcomes in stable COPD patients","volume":"27","author":"de Torres","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2009.01.021_bib12","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1164\/rccm.200605-713OC","article-title":"C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease","volume":"175","author":"Dahl","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2009.01.021_bib13","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1378\/chest.128.4.1995","article-title":"Airway and systemic inflammation and decline in lung function in patients with COPD","volume":"128","author":"Donaldson","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2009.01.021_bib14","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1164\/ajrccm.163.5.2101039","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI\/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary","volume":"163","author":"Pauwels","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2009.01.021_bib15","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1378\/chest.107.2.395","article-title":"Effect of cigarette smoking on pulmonary function in each phenotype M of alpha-1-protease inhibitor","volume":"107","author":"Matsuse","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2009.01.021_bib16","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1183\/09031936.98.12020395","article-title":"Cigarette smoke inhalation and lung damage in smoking volunteers","volume":"12","author":"Clark","year":"1998","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2009.01.021_bib17","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0009-9260(82)80301-2","article-title":"Computed tomography in pulmonary emphysema","volume":"33","author":"Goddard","year":"1982","journal-title":"Clin Radiol"},{"key":"10.1016\/j.rmed.2009.01.021_bib18","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1164\/rccm.2202023","article-title":"Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum","volume":"166","author":"Vernooy","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2009.01.021_bib19","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1164\/ajrccm.161.4.9903022","article-title":"The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease","volume":"161","author":"Takabatake","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2009.01.021_bib20","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1136\/thx.2006.058321","article-title":"Association between markers of emphysema and more severe chronic obstructive pulmonary disease","volume":"61","author":"Boschetto","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2009.01.021_bib21","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1165\/rcmb.2002-0166TR","article-title":"Matrix metalloproteinase-9 in lung remodeling","volume":"28","author":"Atkinson","year":"2003","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.rmed.2009.01.021_bib22","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1136\/thx.2006.064428","article-title":"Profiling serum biomarkers in patients with COPD: associations with clinical parameters","volume":"62","author":"Pinto-Plata","year":"2007","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2009.01.021_bib23","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1378\/chest.127.2.558","article-title":"The interactions between cigarette smoking and reduced lung function on systemic inflammation","volume":"127","author":"Gan","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2009.01.021_bib24","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11883-006-0040-x","article-title":"C-reactive protein and cardiovascular disease: weighing the evidence","volume":"8","author":"Lowe","year":"2006","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.rmed.2009.01.021_bib25","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1136\/thx.2006.059808","article-title":"C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease","volume":"61","author":"Man","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2009.01.021_bib26","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1378\/chest.07-2433","article-title":"C-reactive protein levels and survival in patients with moderate to very severe COPD","volume":"133","author":"de Torres","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2009.01.021_bib27","first-page":"409","article-title":"C-reactive protein: a new risk assessment tool for cardiovascular disease","volume":"105","author":"Clearfield","year":"2005","journal-title":"J Am Osteopath Assoc"},{"key":"10.1016\/j.rmed.2009.01.021_bib28","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.2337\/diabetes.51.5.1596","article-title":"C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study","volume":"51","author":"Freeman","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.rmed.2009.01.021_bib29","series-title":"The natural history of chronic bronchitis and emphysema","author":"Fletcher","year":"1976"},{"key":"10.1016\/j.rmed.2009.01.021_bib30","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1164\/ajrccm.151.6.7767520","article-title":"Effects of smoking and smoking cessation on longitudinal decline in pulmonary function","volume":"151","author":"Burchfiel","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2009.01.021_bib31","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1001\/jama.1994.03520190043033","article-title":"Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study","volume":"272","author":"Anthonisen","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.rmed.2009.01.021_bib32","doi-asserted-by":"crossref","first-page":"969","DOI":"10.7326\/0003-4819-138-12-200306170-00008","article-title":"Long-term effects of inhaled corticosteroids on FEV1 in patients with chronic obstructive pulmonary disease. A meta-analysis","volume":"138","author":"Highland","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rmed.2009.01.021_bib33","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/thorax.58.11.937","article-title":"Inhaled corticosteroids reduce the progression of airflow limitation in chronic obstructive pulmonary disease: a meta-analysis","volume":"58","author":"Sutherland","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2009.01.021_bib34","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1164\/rccm.200404-543OC","article-title":"Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease","volume":"170","author":"Sin","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2009.01.021_bib35","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1164\/rccm.200709-1356OC","article-title":"The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease","volume":"177","author":"Sin","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2009.01.021_bib36","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1182\/blood.V93.8.2730","article-title":"The effect of glucocorticoids on the expression of L-selectin on polymorphonuclear leukocyte","volume":"93","author":"Nakagawa","year":"1999","journal-title":"Blood"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611109000377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611109000377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T10:54:08Z","timestamp":1760612048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611109000377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0954611109000377"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2009.01.021","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2009.01.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}